Engineered carbonaceous nanomaterials manufacturers in the United States: Workforce size, characteristics, and feasibility of epidemiologic studies

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 6 SUPPL., 2011, Pages

  Schubauer Berigan, Mary K ^a   Dahm, Matthew M ^a   Yencken, Marianne S ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CARBON NANOTUBE; ENGINEERED CARBONACEOUS NANOMATERIAL; FULLERENE; GRAPHENE; NANOFIBER; NANOMATERIAL; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; GEOGRAPHY; HEALTH SURVEY; NANOFABRICATION; OCCUPATIONAL EXPOSURE; UNITED STATES; WORK ENVIRONMENT;

EID: 79953828304     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31821b1e2c     Document Type: Article

References (32)

1. Gerritzen G, Huang L-C, Killpack K, et al. A Review of Current Practices in the Nanotechnology Industry, Phase Two Report: Survey of Current Practices in the Nanotechnology Workplace. International Council on Nanotechnology (ICON) technical report; November 13, 2006:140.
2. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol. 2006;36:189-217.
3. Mercer RR, Scabilloni J, Wang L, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294:L87-L97. (Pubitemid 351380321)
4. Shvedova AA, Kisin E, Murray AR, et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, andmutagenesis. Am J Physiol Lung Cell Mol Physiol. 2008;295:L552-L565.
5. Porter DW, Hubbs AF, Mercer RR, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicol. 2010;269:136-147.
6. Duffin R, Mills NL, Donaldson K. Nanoparticles: a thoracic toxicology perspective. Yonsei Med J. 2007;48:561-572.
7. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta. 2011;1810:361-373.
8. Riviere JE. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:26-34.
9. Simeonova PP, Erdely A. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers. Inhal Toxicol. 2009;21(suppl 1):68-73.
10. Mercer RR, Scabilloni JF, Wang L, Battelli LA, Castranova V. Use of labeled single walled carbon nanotubes to study translocation from the lungs. Toxicologist. 2009;108(suppl 1):A2192.
11. Sriram K, Porter DW, Tsuruoka S, et al. Neuroinflammatory responses following exposure to engineered nanomaterials [abstract]. Toxicologist. 2007;96(1):288.
12. Sriram K, Porter DW, Jefferson AM, et al. Neuroinflammation and blood-brain barrier changes following exposure to engineered nanomaterials [abstract]. Toxicologist. 2009;108(1):458.
13. Genaidy A, Tolaymat T, Sequeira R, Rinder M, Dionysiou D. Health effects of exposure to carbon nanofibers: systematic review, critical appraisal, meta analysis and research to practice perspectives. Sci Total Environ. 407:3686-3701.
14. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A. 2004;67:87-107. (Pubitemid 38117533)
15. Methner MM, Birch ME, Evans DE, Ku BK, Crouch K, Hoover MD. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J Occup Environ Hyg. 2007;4:D125-D130.
16. Methner M, Hodson L, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials. Part A. J Occup Environ Hyg. 2010;7:127-132.
17. Evans DE, Ku BK, Birch ME, Dunn KH. Aerosol monitoring during carbon nanofiber production: mobile direct-reading sampling. Ann Occup Hyg. 2010;54:514-531.
18. Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, McKernan JL. Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J Occup Environ Med. 2009;51:323-335.
19. Dahm MM, Yencken MS, Schubauer-Berigan MK. Exposure control strategies in carbonaceous nanomaterial industry. J Occup Environ Med. 2011;53(6 Supp):S68-S73.
20. Lux Research, Inc. The Nanotech Report 4. Investment Overview and Market Research for Nanotechnology. New York, NY: Lux Research, Inc.; 2006:207.
21. Lux Research, Inc. The Nanotech Report 5. Investment Overview and Market Research for Nanotechnology. New York, NY: Lux Research, Inc.; 2007:246.
22. Birch ME. Occupational monitoring of particulate diesel exhaust by NIOSH method 5040. Appl Occup Environ Hyg. 2002;17:400-405.
23. Kuempel ED. Carbon nanotube risk assessment: implications for exposure and medical monitoring. J Occup Environ Med. 2011;53(6 Supp):S90-S96.
24. Loomis D, Dement J, Richardson D, Wolf S. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 2010;67:580-584.
25. International Agency for Research on Cancer (IARC). Identification of Research Needs to Resolve the Carcinogenicity of High-Priority IARC Carcinogens: Views and Expert Opinions of an IARC/NORA Expert Group Meeting: June 30, 2009-July 2, 2009 [IARC Technical Publication No. 42]. Lyon, France: IARC; 2010: 214-215.
26. Geneidy A, Sequeira R, Rinder M, A-Rehim A. Risk analysis and protection measures in a carbon nanofiber manufacturing enterprise: an exploratory investigation. Sci Total Environ. 2009;407:5825-5838.
27. Gereffi G. The New Offshoring of Jobs and Global Development. International Institute for Labour Studies Geneva: International Labour Office; 2006:17-38.
28. Chakraborty C, Agoramoorthy G. A special report on India's biotech scenario: advancement in biopharmaceutical and health care sectors. Biotechnol Adv. 2010;28:1-6.
29. Yang ST, Wang X, Jia G, et al. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice (published online ahead of print August 6, 2008). Toxicol Lett. 181:182-189.
30. Chonan T, Taguchi O, Omae K. Interstitial pulmonary disorders in indium-processing workers. Eur Respir J. 2007;29:317-324. (Pubitemid 46231910)
31. Hamaguchi T, Omae K, Takebayashi T, et al. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Occup Environ Med. 2008;65:51-55.
32. Erdely A, Hulderman T, Salmen R, et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 2009;9:36-43.